Stocksigma LogoStocksigma Logo

Emkay Global Reports Zero Deviation in Preferential Issue Utilization for Q2FY27

CARE Ratings confirmed zero deviation in Emkay Global Financial Services' fund utilization for the quarter ended 30th Sep'26, under its ₹227.52 crore

Emkay Global Reports Zero Deviation in Preferential Issue Utilization for Q2FY27

Emkay Global Financial Services Ltd · Others (Uncategorized) · 29 Oct 2026, 12:31 am

Emkay Global Reports Zero Deviation in Preferential Issue Utilization for Q2FY27 CARE Ratings confirmed zero deviation in Emkay Global Financial Services' fund utilization for the quarter ended 30th Sep'26, under its ₹227.52 crore convertible warrants preferential issue. Cumulative proceeds received reached ₹92.80 crore, including ₹8.08 crore received and fully utilized during Q2FY27 for working capital needs via fixed deposits backing bank guarantees (₹6.29 crore) and exchange margins (₹1.79 crore). Cumulative working capital utilization stood at ₹92.80 crore, leaving ₹109.71 crore uncalled and ₹25.00 crore unutilized for general corporate purposes.

Original exchange filing (PDF)

More announcements from Emkay Global Financial Services Ltd

All Emkay Global Financial Services Ltd announcements